Mobile-health Approach to Gather Clinical Information From Patients Following Hospital Discharge
Determining the Acceptability and Feasibility of Mobile-health Approaches to Gather Clinical Information From Patients at Home Following Hospital Discharge
2 other identifiers
observational
97
1 country
1
Brief Summary
The purpose of this study is to assess the feasibility of using a mobile-health approach to gather clinical data from patients following discharge from the hospital on outpatient parenteral antibiotic therapy (OPAT). The study population will consist of adult participants who have a smartphone that is capable of both text messaging and pairing with a Bluetooth thermometer that will be provided. Following discharge, patients will be asked to respond to two daily text messages. They will also be reminded to take and send in photos of any skin rashes that may develop as well as their PICC-line site during dressing changes. Text messages will be sent for up to 30 days, but will be stopped sooner if the patient is readmitted to the hospital or if OPAT is discontinued. At the end of the 30 days, all patients will be sent a text message survey about usability, the time it took to complete the study tasks, suggestions for future improvements, and whether they would be willing to be interviewed via phone. A subset of the participants will be interviewed via phone to obtain more detailed feasibility data. Information from the patient's medical record will be collected at the time of hospital discharge as well as at the end of the study period. Additionally, a focus group (via conference call) will be conducted with all research team members and infectious disease physicians involved in OPAT who did not use the system to gauge their needs and to get ideas for future applications of our tools.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2020
CompletedFirst Posted
Study publicly available on registry
January 14, 2021
CompletedStudy Start
First participant enrolled
August 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 19, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 19, 2022
CompletedNovember 18, 2023
November 1, 2023
1.2 years
December 11, 2020
November 15, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Number of Days with a Temperature Reading
The number of days that participants submit a temperature reading during the course of the study.
30 days
Number of Completed Surveys
The number of completed surveys that the participant submits over the course of the study.
30 days
Number of Photos Sent
The number of photos that the participant submits over the course of the study.
30 days
Sample Size Estimation for Future Study
The sample size required to conduct a powered study in the future.
30 days
Secondary Outcomes (1)
Suggestions for Future Use survey
30 days
Study Arms (2)
Patient Participants
Adults patients who are discharged from the hospital on outpatient parenteral antibiotic therapy.
Physician Participants
Infectious disease physicians who prescribe OPAT to their patients but were not involved in the study.
Interventions
Focus group with infectious disease physicians who prescribe OPAT to patients but were not involved in the study.
Eligibility Criteria
Patients being discharged from hospital on OPAT.
You may qualify if:
- Age 18 to 100
- Being discharged from hospital on OPAT
- Owns a smartphone capable of text messaging and being paired to Bluetooth thermometer
- Able to send SMS and MMS messages via phone
You may not qualify if:
- Prisoner status
- Unable to provide own written, informed consent
- Infectious disease physician who prescribes OPAT
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philip M Polgreen, MD, MPH
University of Iowa
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Internal Medicine
Study Record Dates
First Submitted
December 11, 2020
First Posted
January 14, 2021
Study Start
August 27, 2021
Primary Completion
November 19, 2022
Study Completion
November 19, 2022
Last Updated
November 18, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share